SUPPLEMENT
Q2 2024 — Financial statement information
Q2 2024PDF · 20 pages232 KB
Three months ended June 30, Six months ended June 30, (Millions, except per share amounts) 2024 2023 2024 2023 Net sales $ 6,255 $ 6,283 $ 12,271 $ 12,338 Operating expenses Cost of sales 3,571 3,728 7,056 7,472 Selling, general and administrative expenses 1,132 11,615 2,260 12,763 Research, development and related expenses 280 298 534 595 Total operating expenses 4,983 15,641 9,850 20,830 Operating income (loss) 1,272 (9,358) 2,421 (8,492) Other expense (income), net (138) 72 82 128 Income (loss) from continuing operations before income taxes 1,410 (9,430) 2,339 (8,620) Provision (benefit) for income taxes 203 (2,261) 423 (2,116) Income (loss) from continuing operations of consolidated group 1,207 (7,169) 1,916 (6,504) Income (loss) from unconsolidated subsidiaries, net of taxes 3 3 4 5 Net income (loss) from continuing operations including noncontrolling interest 1,210 (7,166) 1,920 (6,499) Less: Net income (loss) attributable to noncontrolling interest 6 5 11 10 Net income (loss) from continuing operations attributable to 3M 1,204 (7,171) 1,909 (6,509) Net income (loss) from discontinued operations, net of taxes (59) 330 164 644 Net income (loss) attributable to 3M $ 1,145 $ (6,841) $ 2,073 $ (5,865) Earnings (loss) per share attributable to 3M common shareholders: Weighted average 3M common shares outstanding — basic 553.8 553.9 554.4 553.3 Earnings (loss) per share from continuing operations — basic $ 2.17 $ (12.94) $ 3.44 $ (11.76) Earnings (loss) per share from discontinued operations — basic (0.10) 0.59 0.30 1.16 Earnings (loss) per share — basic $ 2.07 $ (12.35) $ 3.74 $ (10.60) Weighted average 3M common shares outstanding — diluted 554.8 553.9 555.3 553.3 Earnings (loss) per share from continuing operations — diluted $ 2.17 $ (12.94) $ 3.44 $ (11.76) Earnings (loss) per share from discontinued operations — diluted (0.10) 0.59 0.29 1.16 Earnings (loss) per share — diluted $ 2.07 $ (12.35) $ 3.73 $ (10.60) 3M Company and Subsidiaries CONSOLIDATED STATEMENT OF INCOME (LOSS) (Millions, except per-share amounts) (Unaudited) 1 -- 1 of 20 -- June 30, 2024 December 31, 2023 ASSETS Current assets Cash and cash equivalents $ 10,083 $ 5,735 Marketable securities – current 255 50 Accounts receivable – net 3,575 3,601 Inventories 4,060 3,944 Prepaids 444 344 Other current assets 1,098 326 Current assets of discontinued operations — 2,379 Total current assets 19,515 16,379 Property, plant and equipment – net 7,472 7,690 Operating lease right of use assets 610 657 Goodwill and intangible assets – net 7,584 7,705 Other assets 8,196 6,806 Non-current assets of discontinued operations — 11,343 Total assets $ 43,377 $ 50,580 LIABILITIES AND EQUITY Current liabilities Short-term borrowings and current portion of long-term debt $ 1,302 $ 2,947 Accounts payable 2,813 2,776 Accrued payroll 602 695 Accrued income taxes 407 304 Operating lease liabilities – current 169 192 Other current liabilities 9,052 6,660 Current liabilities of discontinued operations — 1,723 Total current liabilities 14,345 15,297 Long-term debt 11,781 13,088 Other liabilities 13,263 16,641 Non-current liabilities of discontinued operations — 686 Total liabilities 39,389 45,712 Total equity 3,988 4,868 Shares outstanding June 30, 2024: 549,353,621 December 31, 2023: 552,581,136 Total liabilities and equity $ 43,377 $ 50,580 3M Company and Subsidiaries CONDENSED CONSOLIDATED BALANCE SHEET (Dollars in millions) (Unaudited) 2 -- 2 of 20 -- Six months ended June 30, 2024 2023 NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 1,788 $ 2,784 Cash flows from investing activities: Purchases of property, plant and equipment (644) (852) Purchases and proceeds from sale or maturities of marketable securities and investments – net (236) 170 Other investing activities 24 63 NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (856) (619) Cash flows from financing activities: Change in debt – net 5,509 (44) Purchases of treasury stock (421) (29) Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 30 218 Dividends paid to shareholders (1,221) (1,655) Cash transferred to Solventum related to separation, net (577) — Other financing activities (57) (9) NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 3,263 (1,519) Effect of exchange rate changes on cash and cash equivalents (45) (43) Net increase (decrease) in cash and cash equivalents 4,150 603 Cash and cash equivalents at beginning of year 5,933 3,655 Cash and cash equivalents at end of period $ 10,083 $ 4,258 The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet. 3M Company and Subsidiaries CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Dollars in millions) (Unaudited) 3 -- 3 of 20 -- Three months ended June 30, 2024 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales 0.7 % 0.6 % (4.6) % (0.3) % Acquisitions 0.5 0.2 — 0.4 Divestitures 1.6 0.1 0.1 0.8 Translation (0.3) (4.0) (0.7) (1.4) Total sales change 2.5 % (3.1) % (5.2) % (0.5) % Six months ended June 30, 2024 Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle East and Africa Worldwide Organic sales (0.6) % 1.1 % (1.6) % (0.3) % Acquisitions 0.7 0.1 — 0.4 Divestitures 0.8 — (0.1) 0.4 Translation 0.1 (4.0) 0.4 (1.0) Total sales change 1.0 % (2.8) % (1.3) % (0.5) % Three months ended June 30, 2024 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial 1.1 % — % — % (1.3) % (0.2) % Transportation and Electronics (1.3) 1.0 — (1.9) (2.2) Consumer (1.4) — — (1.0) (2.4) Six months ended June 30, 2024 Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales change Safety and Industrial (0.2) % — % — % (0.7) % (0.9) % Transportation and Electronics 0.6 1.2 — (1.6) 0.2 Consumer (2.6) — — (0.7) (3.3) 3Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post- transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum. 3M Company and Subsidiaries SALES CHANGE ANALYSIS3 (Unaudited) 4 -- 4 of 20 -- 3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M operating income (loss) and income before taxes. Business segment operating income (loss) excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Unallocated and Other”). 3M made certain changes to the composition of segment information reviewed by 3M's chief operating decision maker (CODM) effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its business segments effective in the first quarter of 2024. Accordingly, information provided herein reflects the impact of these changes for all applicable periods presented. Effective in the second quarter of 2024, this change included the following: Elimination of former Health Care business segment • The former Health Care business segment was eliminated in the second quarter of 2024 in connection with the separation of Solventum and reflection of its historical net income and applicable assets and liabilities included in the Separation as discontinued operations within 3M's financial statements. Addition of ‘Other’ and update to ‘Corporate and Unallocated’ • 3M added the “Other” category of information as a result of the Separation. It principally reflects activity associated with: ◦ Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Separation, as well as other applicable divestitures. ◦ Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with those previous divestitures. • Activity included in 3M’s existing “Corporate and Unallocated” was updated primarily to additionally reflect: ◦ Removal of costs related to separating and divesting Solventum that were eligible to be part of discontinued operations. ◦ Commercial activity with Solventum post-Separation and certain operations of the former Health Care business segment retained by 3M. ◦ Costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations (and prospectively, post-spin, became additional costs allocated to remaining business segments) other than those beginning in the first quarter of 2024 included in “Other” associated with transition arrangement activity for which 3M began to charge fees in April 2024. In addition, effective in the first quarter of 2024, 3M made certain changes within its business segments as described below. While they impacted the composition of certain divisions within business segments, they did not change the overall composition of segments or the measure of segment operating performance used by 3M’s CODM. Creation of Industrial Specialties division (within Safety and Industrial business segment) and Commercial Branding and Transportation division (within Transportation and Electronics business segment) • 3M created the Industrial Specialties division within the Safety and Industrial business segment, which consists of the former Closure and Masking Systems division along with certain products formerly within the Industrial Adhesive and Tapes division and the Personal Safety division. Further, 3M created the Commercial Branding and Transportation division within the Transportation and Electronics business segment, which consists of the former Commercial Solutions division and the Transportation Safety division. Re-alignment of divisions within Consumer business segment • Within the Consumer business segment, the business re-aligned to the following four divisions: Consumer Safety and Well-Being, Home and Auto Care, Home Improvement, and Packaging and Expression. 3M Company and Subsidiaries BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION (Unaudited) 5 -- 5 of 20 -- BUSINESS SEGMENT INFORMATION Three months ended June 30, Six months ended June 30, NET SALES (Millions) 2024 2023 2024 2023 Safety and Industrial $ 2,759 $ 2,765 $ 5,491 $ 5,544 Transportation and Electronics 2,143 2,191 4,247 4,241 Consumer 1,263 1,293 2,403 2,485 Corporate and Unallocated 86 22 112 45 Other 4 12 18 23 Total Company $ 6,255 $ 6,283 $ 12,271 $ 12,338 BUSINESS SEGMENT INFORMATION Three months ended June 30, Six months ended June 30, OPERATING INCOME (LOSS) (Millions) 2024 2023 2024 2023 Safety and Industrial $ 612 $ 534 $ 1,269 $ 1,135 Transportation and Electronics 428 410 909 704 Consumer 219 235 435 414 Corporate and Unallocated Corporate special items: Net costs for significant litigation (8) (10,357) (71) (10,439) Divestiture costs (14) (1) (20) (4) Russia exit (charges) benefits — 18 — 18 Total corporate special items (22) (10,340) (91) (10,425) Other corporate (expense) income - net (2) (207) (73) (339) Total Corporate and Unallocated (24) (10,547) (164) (10,764) Other 37 10 (28) 19 Total Company operating income (loss) 1,272 (9,358) 2,421 (8,492) Other expense/(income), net (138) 72 82 128 Income (loss) before income taxes $ 1,410 $ (9,430) $ 2,339 $ (8,620) Corporate and Unallocated and Other Outside of 3M's operating segments, 3M has Corporate and Unallocated and Other which are not reportable business segments as they do not meet the segment reporting criteria. Because Corporate and Unallocated and Other include a variety of miscellaneous items, they are subject to fluctuation on a quarterly and annual basis. • Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense- net”. ◦ Corporate special items include net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were also included in corporate special items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were not included in the Corporate net costs for significant litigation special item, instead being reflected in the Safety and Industrial business segment. Corporate special items for the periods presented also include divestiture costs and Russia exit costs/ benefits. Divestiture costs include costs that were not eligible to be part of discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. ◦ Other corporate expense-net includes certain enterprise and governance activities resulting in unallocated corporate costs and other activity and net costs that 3M may choose not to allocate directly to its business segments. Other corporate expense-net also includes costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations, commercial activity with Solventum post-Separation, and certain operations of the former Health Care business segment retained by 3M. 3M Company and Subsidiaries BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION - (CONTINUED) (Unaudited) 6 -- 6 of 20 -- • Other principally reflects activity associated with: ◦ Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with those previous divestitures. ◦ Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Separation, as well as other applicable divestitures. The table below provides disaggregated revenue information for full-year 2023 revised to reflect the changes to composition of segment information effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its business segments effective in the first quarter of 2024. Similar information relative to applicable periods will be included in 3M’s Form 10-Q filed for the second quarter of 2024. The information below should be read together with information in 3M’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Reports on Form 10-Q during the year ended December 31, 2023 (including the consolidated financial statements, notes thereto and Management’s Discussion and Analysis included in those documents), along with information included in 3M’s Current Reports on Form 8-K filed April 4, 2024. The financial information that follows does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary, unaudited, and based on current estimates, and remains subject to change. Disaggregated revenue information Net sales by division reflecting continuing operations (millions) 2023 Abrasives $ 1,327 Automotive Aftermarket 1,237 Electrical Markets 1,285 Industrial Adhesives and Tapes 2,051 Industrial Specialties 1,180 Personal Safety 3,382 Roofing Granules 494 Total Safety and Industrial Business Segment 10,956 Advanced Materials 1,167 Automotive and Aerospace 1,925 Commercial Branding and Transportation 2,546 Electronics 2,863 Total Transportation and Electronics Business Segment 8,501 Consumer Safety and Well-Being 1,096 Home and Auto Care 1,260 Home Improvement 1,448 Packaging and Expression 1,222 Total Consumer Business Segment 5,026 Corporate and Unallocated 90 Other 37 Total Company $ 24,610 Net sales by geographic area reflecting continuing operations (millions) 2023 Americas $ 13,268 Asia Pacific 7,068 Europe, Middle East and Africa 4,274 Worldwide $ 24,610 3M Company and Subsidiaries BUSINESS SEGMENTS AND DISAGGREGATED REVENUE INFORMATION - (CONTINUED) (Unaudited) 7 -- 7 of 20 -- In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies. Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable. This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include: GAAP amounts for which a measure adjusted for special items is also provided: Reasons 3M believes the measure is useful: • Net sales (and sales change) Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items • Operating income (loss), segment operating income (loss) and operating income (loss) margin • Other expense (income), net • Income (loss) from continuing operations before taxes • Provision for income taxes and effective tax rate • Net income (loss) from continuing operations • Earnings (loss) per share from continuing operations Additional non-GAAP measures: • Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance • Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in analyses of ongoing underlying operating trends • Net debt Meaningful as indicator of liquidity and measure of capital structure strategy The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 8 -- 8 of 20 -- Certain amounts adjusted for special items (non-GAAP measures): Three months ended June 30, 2023 (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Safety and Industrial GAAP amounts $ 534 19.3 % Adjustments for special items: Net costs for significant litigation 80 Total special items 80 Adjusted amounts (non-GAAP measures)4 $ 614 22.2 % Transportation and Electronics GAAP amounts $ 2,191 $ 410 18.7 % Adjustments for special items: Manufactured PFAS products (332) (41) Total special items (332) (41) Adjusted amounts (non-GAAP measures)4 $ 1,859 $ 369 19.8 % Total Company GAAP amounts $ 6,283 $ (9,358) (148.9) % $ 72 $ (9,430) $ (2,261) 24.0 % $ (7,171) $ (12.94) Adjustments for special items: Net costs for significant litigation5 — 10,437 (12) 10,449 2,457 7,992 14.43 Manufactured PFAS products (332) (41) — (41) (10) (31) (0.06) Russia exit charges (benefits) — (18) — (18) 3 (21) (0.04) Divestiture costs — 1 — 1 — 1 — Total special items (332) 10,379 (12) 10,391 2,450 7,941 14.33 Adjusted amounts (non-GAAP measures)4 $ 5,951 $ 1,021 17.2 % $ 60 $ 961 $ 189 19.5 % $ 770 $ 1.39 Three months ended June 30, 2024 (Dollars in millions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Earnings per diluted share from continuing operations percent change Safety and Industrial GAAP amounts $ 612 22.2 % Adjustments for special items: Net costs for significant litigation 11 Total special items 11 Adjusted amounts (non-GAAP measures)4 $ 623 22.6 % Transportation and Electronics GAAP amounts $ 2,143 (2.2) % $ 428 20.0 % Adjustments for special items: Manufactured PFAS products (236) (2) Total special items (236) (2) Adjusted amounts (non-GAAP measures)4 $ 1,907 2.6 % $ 426 22.3 % Total Company GAAP amounts $ 6,255 (0.5) % $ 1,272 20.3 % $ (138) $ 1,410 $ 203 14.4 % $ 1,204 $ 2.17 117 % Adjustments for special items: Net costs for significant litigation — 19 (202) 221 (25) 246 0.44 Manufactured PFAS products (236) (2) — (2) (1) (1) — Divestiture costs — 14 — 14 (113) 127 0.23 Solventum ownership - change in value — — 1,113 (1,113) — (1,113) (2.00) Pension risk transfer charge — — (795) 795 188 607 1.09 Total special items (236) 31 116 (85) 49 (134) (0.24) Adjusted amounts (non-GAAP measures)4 $ 6,019 1.1 % $ 1,303 21.6 % $ (22) $ 1,325 $ 252 19.1 % $ 1,070 $ 1.93 39 % 4These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion. 5For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for both basic and diluted loss per share in periods of resulting net losses. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES – (CONTINUED) (Unaudited) 9 -- 9 of 20 -- Six months ended June 30, 2023 (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Safety and Industrial GAAP amounts $ 1,135 20.5 % Adjustments for special items: Net costs for significant litigation 41 Total special items 41 Adjusted amounts (non-GAAP measures)4 $ 1,176 21.2 % Transportation and Electronics GAAP amounts $ 4,241 $ 704 16.6 % Adjustments for special items: Manufactured PFAS products (677) (51) Total special items (677) (51) Adjusted amounts (non-GAAP measures)4 $ 3,564 $ 653 18.3 % Total Company GAAP amounts $ 12,338 $ (8,492) (68.8) % $ 128 $ (8,620) $ (2,116) 24.6 % $ (6,509) $ (11.76) Adjustments for special items: Net costs for significant litigation5 — 10,480 (12) 10,492 2,464 8,028 14.51 Manufactured PFAS products (677) (51) — (51) (13) (38) (0.07) Russia exit charges (benefits) — (18) — (18) 3 (21) (0.04) Divestiture costs — 4 — 4 — 4 0.01 Total special items (677) 10,415 (12) 10,427 2,454 7,973 14.41 Adjusted amounts (non-GAAP measures)4 $ 11,661 $ 1,923 16.5 % $ 116 $ 1,807 $ 338 18.7 % $ 1,464 $ 2.65 Six months ended June 30, 2024 (Dollars in millions, except per share amounts) Net sales Sales change Operating income (loss) Operating income (loss) margin Other expense (income), net Income (loss) from continuing operations before taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Earnings per diluted share from continuing operations percent change Safety and Industrial GAAP amounts $ 1,269 23.1 % Adjustments for special items: Net costs for significant litigation 18 Total special items 18 Adjusted amounts (non-GAAP measures)4 $ 1,287 23.4 % Transportation and Electronics GAAP amounts $ 4,247 0.2 % $ 909 21.4 % Adjustments for special items: Manufactured PFAS products (517) (4) Total special items (517) (4) Adjusted amounts (non-GAAP measures)4 $ 3,730 4.7 % $ 905 24.3 % Total Company GAAP amounts $ 12,271 (0.5) % $ 2,421 19.7 % $ 82 $ 2,339 $ 423 18.1 % $ 1,909 $ 3.44 129 % Adjustments for special items: Net costs for significant litigation — 89 (406) 495 6 489 0.88 Manufactured PFAS products (517) (4) — (4) (2) (2) — Divestiture costs — 20 — 20 (111) 131 0.24 Solventum ownership - change in value — — 1,113 (1,113) — (1,113) (2.01) Pension risk transfer charge — — (795) 795 188 607 1.09 Total special items (517) 105 (88) 193 81 112 0.20 Adjusted amounts (non-GAAP measures)4 $ 11,754 0.8 % $ 2,526 21.5 % $ (6) $ 2,532 $ 504 19.9 % $ 2,021 $ 3.64 38 % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (Unaudited) 10 -- 10 of 20 -- 2024 forecast 2024 adjusted earnings per share from continuing operations (non-GAAP measure)4,6 $7.00 to $7.30 2024 adjusted effective tax rate (non-GAAP measure)4,6 19% to 20% 63M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”. Three months ended June 30, 2024 Sales Change3 Organic sales Acquisitions Divestitures Translation Total sales change Total Company (0.3) % 0.4 % 0.8 % (1.4) % (0.5) % Remove manufactured PFAS products special item impact 1.5 — 0.1 — 1.6 Adjusted total Company (non-GAAP measures)4 1.2 % 0.4 % 0.9 % (1.4) % 1.1 % Transportation and Electronics (1.3) % 1.0 % — % (1.9) % (2.2) % Remove manufactured PFAS products special item impact 4.6 0.1 — 0.1 4.8 Adjusted Transportation and Electronics (non-GAAP measures)4 3.3 % 1.1 % — % (1.8) % 2.6 % By Geographic Area Americas 0.7 % 0.5 % 1.6 % (0.3) % 2.5 % Remove manufactured PFAS products special item impact 0.3 — — 0.1 0.4 Adjusted Americas (non-GAAP measures)4 1.0 % 0.5 % 1.6 % (0.2) % 2.9 % Asia Pacific 0.6 % 0.2 % 0.1 % (4.0) % (3.1) % Remove manufactured PFAS products special item impact 3.0 (0.1) 0.1 0.1 3.1 Adjusted Asia Pacific (non-GAAP measures)4 3.6 % 0.1 % 0.2 % (3.9) % — % Europe, Middle East & Africa (4.6) % — % 0.1 % (0.7) % (5.2) % Remove manufactured PFAS products special item impact 2.6 0.1 — (0.1) 2.6 Adjusted Europe, Middle East & Africa (non-GAAP measures)4 (2.0) % 0.1 % 0.1 % (0.8) % (2.6) % 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 11 -- 11 of 20 -- Six months ended June 30, 2024 Sales Change3 Organic sales Acquisitions Divestitures Translation Total sales change Total Company (0.3) % 0.4 % 0.4 % (1.0) % (0.5) % Remove manufactured PFAS products special item impact 1.3 — — — 1.3 Adjusted total Company (non-GAAP measures)4 1.0 % 0.4 % 0.4 % (1.0) % 0.8 % Transportation and Electronics 0.6 % 1.2 % — % (1.6) % 0.2 % Remove manufactured PFAS products special item impact 4.3 0.2 — — 4.5 Adjusted Transportation and Electronics (non-GAAP measures)4 4.9 % 1.4 % — % (1.6) % 4.7 % By Geographic Area Americas (0.6) % 0.7 % 0.8 % 0.1 % 1.0 % Remove manufactured PFAS products special item impact 0.6 — — — 0.6 Adjusted Americas (non-GAAP measures)4 — % 0.7 % 0.8 % 0.1 % 1.6 % Asia Pacific 1.1 % 0.1 % — % (4.0) % (2.8) % Remove manufactured PFAS products special item impact 2.6 — — — 2.6 Adjusted Asia Pacific (non-GAAP measures)4 3.7 % 0.1 % — % (4.0) % (0.2) % Europe, Middle East & Africa (1.6) % — % (0.1) % 0.4 % (1.3) % Remove manufactured PFAS products special item impact 1.3 0.1 (0.1) — 1.3 Adjusted Europe, Middle East & Africa (non-GAAP measures)4 (0.3) % 0.1 % (0.2) % 0.4 % — % Full-Year 2024 Forecast Sales Change3 Organic sales Acquisitions Divestitures Translation Total sales change Total Company6 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75% Remove manufactured PFAS products impact6 — — — — — Adjusted total Company (non-GAAP measures)4,6 flat to +2% — % 0.75 % (1) % (0.25%) to +1.75% 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 12 -- 12 of 20 -- Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non- GAAP measures): Three months ended June 30, Six months ended June 30, Major GAAP Cash Flow Categories (dollars in millions) 2024 2023 2024 2023 Net cash provided by (used in) operating activities $ 1,021 $ 1,509 $ 1,788 $ 2,784 Net cash provided by (used in) investing activities (463) (233) (856) (619) Net cash provided by (used in) financing activities (1,358) (803) 3,263 (1,519) Three months ended June 30, Six months ended June 30, Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2024 2023 2024 2023 Net cash provided by (used in) operating activities $ 1,021 $ 1,509 $ 1,788 $ 2,784 Adjustments for special items: Net costs for significant litigation after-tax payment impacts 122 101 473 159 Divestiture costs after-tax payment impacts 136 74 275 117 Divestiture-related restructuring after-tax payment impacts 1 5 2 7 TCJA transition tax payment 193 126 193 126 Manufactured PFAS products impact after-tax payment impacts (58) (24) (128) (11) Total adjustments for special items 394 282 815 398 Adjusted net cash provided by (used in) operating activities (non-GAAP measure)7 $ 1,415 $ 1,791 $ 2,603 $ 3,182 Purchases of property, plant and equipment (PPE) (269) (377) (644) (852) Manufactured PFAS products impact - removing related purchases of PPE 19 49 39 79 Adjusted purchases of PPE (non-GAAP measure)7 $ (250) $ (328) $ (605) $ (773) Adjusted free cash flow (non-GAAP measure)7 $ 1,165 $ 1,463 $ 1,998 $ 2,409 Net income (loss) attributable to 3M $ 1,145 $ (6,841) $ 2,073 $ (5,865) Adjustments for special items, net of tax: Net costs for significant litigation 246 7,992 489 8,028 Manufactured PFAS products impact (1) (31) (2) (38) Russia exit charges (benefits) — (21) — (21) Divestiture costs 184 105 341 187 Solventum ownership - change in value (1,113) — (1,113) — Pension risk transfer charge 607 — 607 — Total adjustments for special items, net of tax (77) 8,045 322 8,156 Net income (loss) attributable to 3M adjusted for special items (used for adjusted free cash flow calculation) $ 1,068 $ 1,204 $ 2,395 $ 2,291 Adjusted free cash flow conversion (non-GAAP measure)7 109 % 122 % 83 % 105 % 73M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations; accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued operations both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items (used for adjusted free cash flow calculation). 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 13 -- 13 of 20 -- Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures): Adjusted EBITDA (non-GAAP measure)8 Adjusted EBITDA margin (non-GAAP measure)8 Three months ended June 30, Six months ended June 30, Three months ended June 30, Six months ended June 30, (Dollars in millions) 2024 2023 2024 2023 2024 2023 2024 2023 Safety and Industrial $ 760 $ 746 $ 1,559 $ 1,442 27.6 % 27.0 % 28.4 % 26.0 % Transportation and Electronics 510 446 1,072 807 26.8 % 23.9 % 28.8 % 22.6 % Consumer 258 273 512 490 20.5 % 21.1 % 21.3 % 19.7 % Corporate and Unallocated and Other 48 (164) (78) (238) Total Company $ 1,576 $ 1,301 $ 3,065 $ 2,501 26.2 % 21.9 % 26.1 % 21.5 % Three months ended June 30, Six months ended June 30, Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2024 2023 2024 2023 Adjusted net sales (non-GAAP measure)4 $ 6,019 $ 5,951 $ 11,754 $ 11,661 Net income (loss) from continuing operations attributable to 3M 1,204 (7,171) 1,909 (6,509) Add/(subtract): Net income/(loss) attributable to noncontrolling interest 6 5 11 10 (Income)/loss from unconsolidated subsidiaries, net of taxes (3) (3) (4) (5) Provision for income taxes 203 (2,261) 423 (2,116) Other expense/(income): Interest (Income)/expense 179 97 410 179 Pension & OPEB non-service cost (benefit) 796 (25) 785 (51) Solventum ownership - change in value (1,113) — (1,113) — Depreciation and amortization (DA) expense 302 311 592 638 Adjustments for special items: Net costs for significant litigation 19 10,437 89 10,480 Manufactured PFAS products impact: Remove manufactured PFAS products operating (income) loss (2) (41) (4) (51) Subtract PFAS-related amount included in DA above (29) (31) (53) (60) Russia exit charges (benefits) — (18) — (18) Divestiture costs 14 1 20 4 Total special items 2 10,348 52 10,355 Adjusted EBITDA (non-GAAP measure)8 $ 1,576 $ 1,301 $ 3,065 $ 2,501 Adjusted EBITDA margin (non-GAAP measure)8 26.2 % 21.9 % 26.1 % 21.5 % 83M defines adjusted EBITDA as net income (loss) from continuing operations attributable to 3M, adjusted for net income/(loss) attributable to noncontrolling interest,(income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income (loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted EBITDA divided by net sales, adjusted for special items. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 14 -- 14 of 20 -- Adjusted EBITDA (non-GAAP measure) Three months ended June 30, 2024 (dollars in millions) Safety and Industrial Transportation and Electronics Consumer Corporate and Unallocated and Other Total Company Adjusted net sales (non-GAAP measure)4 $ 2,759 $ 1,907 $ 1,263 $ 90 $ 6,019 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4 $ 623 $ 426 $ 219 $ 35 $ 1,303 Add/(subtract): Add depreciation and amortization (DA) expense 137 113 39 13 302 Subtract PFAS-related amount included in DA above — (29) — — (29) Adjusted EBITDA (non-GAAP measure)8 $ 760 $ 510 $ 258 $ 48 $ 1,576 Adjusted EBITDA margin (non-GAAP measure)8 27.6 % 26.8 % 20.5 % 26.2 % Three months ended June 30, 2023 (dollars in millions) Adjusted net sales (non-GAAP measure)4 $ 2,765 $ 1,859 $ 1,293 $ 34 $ 5,951 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4 $ 614 $ 369 $ 235 $ (197) $ 1,021 Add/(subtract): Add depreciation and amortization (DA) expense 132 108 38 33 311 Subtract PFAS-related amount included in DA above — (31) — — (31) Adjusted EBITDA (non-GAAP measure)8 $ 746 $ 446 $ 273 $ (164) $ 1,301 Adjusted EBITDA margin (non-GAAP measure)8 27.0 % 23.9 % 21.1 % 21.9 % Six months ended June 30, 2024 (dollars in millions) Adjusted net sales (non-GAAP measure)4 $ 5,491 $ 3,730 $ 2,403 $ 130 $ 11,754 Business segment operating income (loss) (measure of segment operating performance), adjusted for special items (non-GAAP measure)4 $ 1,287 $ 905 $ 435 $ (101) $ 2,526 Add/(subtract): Add depreciation and amortization (DA) expense 272 220 77 23 592 Subtract PFAS-related amount included in DA above — (53) — — (53) Adjusted EBITDA (non-GAAP measure)8 $ 1,559 $ 1,072 $ 512 $ (78) $ 3,065 Adjusted EBITDA margin (non-GAAP measure)8 28.4 % 28.8 % 21.3 % 26.1 % Six months ended June 30, 2023 (dollars in millions) Adjusted net sales (non-GAAP measure)4 $ 5,544 $ 3,564 $ 2,485 $ 68 $ 11,661 Business segment operating income (measure of segment operating performance), adjusted for special items (non-GAAP measure)4 $ 1,176 $ 653 $ 414 $ (320) $ 1,923 Add/(subtract): Add depreciation and amortization (DA) expense 266 214 76 82 638 Subtract PFAS-related amount included in DA above — (60) — — (60) Adjusted EBITDA (non-GAAP measure)8 $ 1,442 $ 807 $ 490 $ (238) $ 2,501 Adjusted EBITDA margin (non-GAAP measure)8 26.0 % 22.6 % 19.7 % 21.5 % Net debt (non-GAAP measure): Net Debt (non-GAAP measure) June 30, 2024 December 31, 2023 Total debt $ 13,083 $ 16,035 Less: Cash, cash equivalents and marketable securities 10,372 5,805 Net debt (non-GAAP measure)9 $ 2,711 $ 10,230 9The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities all on a continuing operations basis. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 15 -- 15 of 20 -- Reflecting Solventum as a discontinued operation for certain historical periods—amounts adjusted for special items (non-GAAP measures): The tables below provide summaries of certain supplemental historical financial information (1) revised to reflect Solventum as a discontinued operation and (2) further adjusted for special items (non-GAAP measures). This information should be read together with information in 3M’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, Annual Report on Form 10-K for the year ended December 31, 2023, and Quarterly Reports on Form 10-Q during the year ended December 31, 2023 (including the consolidated financial statements, notes thereto and Management’s Discussion and Analysis included in those documents), along with information included in 3M’s Current Reports on Form 8-K filed April 4, 2024. The financial information that follows does not revise or otherwise amend or restate any previously filed financial information of 3M. This information is preliminary, unaudited, and based on current estimates, and remains subject to change. The term "N/M" used herein references "not meaningful" for certain percent computations. Reflecting Solventum as a discontinued operation The table below provides a summary of certain supplemental financial information as revised to reflect the reclassification of Solventum’s net income to discontinued operations, thus reflecting the continuing operations of 3M. Reflecting continuing operations (Millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per share from continuing operations — diluted Q1 2024 $ 6,016 $ 1,149 19.1 % 23.7 % $ 705 $ 1.27 Q1 2023 6,055 866 14.3 17.9 662 1.20 Q2 2023 6,283 (9,358) N/M 24.0 (7,171) (12.94) Q3 2023 6,270 (3,096) (49.4) 23.5 (2,527) (4.56) Q4 2023 6,002 899 15.0 3.9 634 1.14 Full-Year 2023 24,610 (10,689) (43.4) 25.4 (8,402) (15.17) Full-Year 2022 26,161 4,369 16.7 4.5 4,013 7.07 Full-Year 2021 27,224 4,929 18.1 17.1 3,935 6.72 Reflecting Solventum as a discontinued operation — amounts adjusted for special items (non-GAAP measures) The table below provides a summary of certain supplemental financial information adjusted for special items (non-GAAP measures) as revised to reflect the reclassification of Solventum’s net income to discontinued operations. Continuing operations adjusted amounts (non-GAAP measures) (Millions, except per share amounts) Net sales Operating income Operating income margin Effective tax rate Net income from continuing operations attributable to 3M Earnings per share from continuing operations — diluted Q1 2024 $ 5,735 $ 1,223 21.3 % 20.9 % $ 951 $ 1.71 Q1 2023 5,710 902 15.8 17.7 694 1.26 Q2 2023 5,951 1,021 17.2 19.5 770 1.39 Q3 2023 5,978 1,292 21.6 24.8 934 1.68 Q4 2023 5,682 1,129 19.9 13.6 948 1.70 Full-Year 2023 23,321 4,344 18.6 19.2 3,346 6.04 Full-Year 2022 24,810 4,717 19.0 16.6 3,796 6.69 Full-Year 2021 25,966 5,257 20.2 17.5 4,188 7.15 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 16 -- 16 of 20 -- The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures. Three months ended March 31, 2024 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 6,016 $ 1,149 19.1 % $ 929 $ 220 23.7 % $ 705 $ 1.27 Adjustments for special items: Net costs for significant litigation — 70 274 31 243 0.44 Manufactured PFAS products (281) (2) (2) (1) (1) — Divestiture costs — 6 6 2 4 — Total special items (281) 74 278 32 246 0.44 Continuing operations adjusted amounts (non-GAAP measures) $ 5,735 $ 1,223 21.3 % $ 1,207 $ 252 20.9 % $ 951 $ 1.71 Three months ended March 31, 2023 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 6,055 $ 866 14.3 % $ 810 $ 145 17.9 % $ 662 $ 1.20 Adjustments for special items: Net costs for significant litigation — 43 43 7 36 0.07 Manufactured PFAS products (345) (10) (10) (3) (7) (0.01) Divestiture costs — 3 3 — 3 — Total special items (345) 36 36 4 32 0.06 Continuing operations adjusted amounts (non-GAAP measures) $ 5,710 $ 902 15.8 % $ 846 $ 149 17.7 % $ 694 $ 1.26 Three months ended June 30, 2023 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 6,283 $ (9,358) N/M $ (9,430) $ (2,261) 24.0 % $ (7,171) $ (12.94) Adjustments for special items: Net costs for significant litigation — 10,437 10,449 2,457 7,992 14.43 Manufactured PFAS products (332) (41) (41) (10) (31) (0.06) Russia exit charges (benefits) — (18) (18) 3 (21) (0.04) Divestiture costs — 1 1 — 1 — Total special items (332) 10,379 10,391 2,450 7,941 14.33 Continuing operations adjusted amounts (non-GAAP measures) $ 5,951 $ 1,021 17.2 % $ 961 $ 189 19.5 % $ 770 $ 1.39 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 17 -- 17 of 20 -- Three months ended September 30, 2023 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 6,270 $ (3,096) (49.4) % $ (3,302) $ (777) 23.5 % $ (2,527) $ (4.56) Adjustments for special items: Net costs for significant litigation — 4,312 4,469 1,068 3,401 6.13 Manufactured PFAS products (292) 105 105 25 80 0.15 Gain on business divestiture — (36) (36) (11) (25) (0.05) Divestiture costs — 7 7 2 5 0.01 Total special items (292) 4,388 4,545 1,084 3,461 6.24 Continuing operations adjusted amounts (non-GAAP measures) $ 5,978 $ 1,292 21.6 % $ 1,243 $ 307 24.8 % $ 934 $ 1.68 Three months ended December 31, 2023 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 6,002 $ 899 15.0 % $ 651 $ 26 3.9 % $ 634 $ 1.14 Adjustments for special items: Net costs for significant litigation — 77 284 83 201 0.36 Manufactured PFAS products (320) 151 151 38 113 0.20 Divestiture costs — 2 2 2 — — Total special items (320) 230 437 123 314 0.56 Continuing operations adjusted amounts (non-GAAP measures) $ 5,682 $ 1,129 19.9 % $ 1,088 $ 149 13.6 % $ 948 $ 1.70 Year ended December 31, 2023 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 24,610 $ (10,689) (43.4) % $ (11,271) $ (2,867) 25.4 % $ (8,402) $ (15.17) Adjustments for special items: Net costs for significant litigation — 14,869 15,245 3,615 11,630 21.00 Manufactured PFAS products (1,289) 205 205 50 155 0.28 Gain on business divestitures — (36) (36) (11) (25) (0.05) Russia exit charges (benefits) — (18) (18) 3 (21) (0.04) Divestiture costs — 13 13 4 9 0.02 Total special items (1,289) 15,033 15,409 3,661 11,748 21.21 Continuing operations adjusted amounts (non-GAAP measures) $ 23,321 $ 4,344 18.6 % $ 4,138 $ 794 19.2 % $ 3,346 $ 6.04 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 18 -- 18 of 20 -- Year ended December 31, 2022 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 26,161 $ 4,369 16.7 % $ 4,204 $ 188 4.5 % $ 4,013 $ 7.07 Adjustments for special items: Net costs for significant litigation — 2,291 2,291 476 1,815 3.20 Manufactured PFAS products (1,351) 631 631 121 510 0.90 Gain on business divestitures — (2,724) (2,724) (39) (2,685) (4.73) Russia exit charges (benefits) — 101 101 (2) 103 0.19 Divestiture-related restructuring actions — 41 41 9 32 0.05 Divestiture costs — 8 8 — 8 0.01 Total special items (1,351) 348 348 565 (217) (0.38) Continuing operations adjusted amounts (non-GAAP measures) $ 24,810 $ 4,717 19.0 % $ 4,552 $ 753 16.6 % $ 3,796 $ 6.69 Year ended December 31, 2021 Reflecting continuing operations (Dollars in millions, except per share amounts) Net sales Operating income (loss) Operating income (loss) margin Income (loss) from continuing operations before income taxes Provision (benefit) for income taxes Effective tax rate Net income (loss) from continuing operations attributable to 3M Earnings (loss) per diluted share from continuing operations Reflecting continuing operations $ 27,224 $ 4,929 18.1 % $ 4,746 $ 813 17.1 % $ 3,935 $ 6.72 Adjustments for special items: Net costs for significant litigation — 463 463 104 359 0.61 Manufactured PFAS products (1,258) (135) (135) (29) (106) (0.18) Total special items (1,258) 328 328 75 253 0.43 Continuing operations adjusted amounts (non-GAAP measures) $ 25,966 $ 5,257 20.2 % $ 5,074 $ 888 17.5 % $ 4,188 $ 7.15 Description of special items: In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these non-GAAP measures for the periods presented include the items described below: Net costs for significant litigation: • These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities (including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along with the associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), and foreign tax credits. 3M does not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Unallocated. In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs associated with the Aearo portion of respirator mask/asbestos matters were reflected in corporate special items in Corporate and Unallocated. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were reflected as part of special items in the Safety and Industrial business segment. In the second quarter of 2024 and 2023, 3M reflected net payments of approximately $428 million and $129 million, respectively, related to net costs for significant litigation. In the first six months of 2024 and 2023, 3M made payments of approximately $799 million and $202 million, respectively, related to net costs for significant litigation. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 19 -- 19 of 20 -- Divestiture costs: • These include certain limited costs that were not eligible to be included within discontinued operations related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of update to 3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs that included within discontinued operations, including interest expense on debt issued by Solventum for the period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity structuring associated with the separation of Solventum. In the second quarter of 2024 and 2023, 3M made payments of approximately $58 million and $94 million, respectively, associated with divestiture costs. In the first six months of 2024 and 2023, 3M made payments of approximately $192 million and $148 million, respectively, associated with divestiture costs. Gain on business divestitures: • In the third quarter of 2023, 3M recorded a gain related to the sale of its dental local anesthetic business partially offset by a loss associated with a previously contingent indemnification obligation from a 2020 divestiture. • In 2022, 3M recorded a gain related to the split-off and combination of its Food Safety business with Neogen Corporation. Russia exit charges/benefits: • In the second quarter of 2023, 3M recorded a gain on final disposal of net assets in Russia. Previously, in the third quarter of 2022, 3M recorded a charge primarily related to impairment of these assets in connection with management's committed exit and disposal plan. Divestiture-related restructuring actions: • In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of amounts previously allocated to the divested business. In the second quarter of 2023, 3M made payments of approximately $5 million associated with divestiture-related restructuring actions. In the first six months of 2024 and 2023, 3M made payments of approximately $2 million and $8 million, respectively, associated with divestiture-related restructuring actions. Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA): • In the second quarter of 2024 and 2023, 3M made payments of approximately $193 million and $126 million, respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA. Manufactured PFAS products: • These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment. Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non- service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated payments. Pension risk transfer charge: • In the second quarter of 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income), net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance company. Solventum ownership - change in value: • This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in other expense (income), net. 3M Company and Subsidiaries SUPPLEMENTAL FINANCIAL INFORMATION NON-GAAP MEASURES (CONTINUED) (Unaudited) 20 -- 20 of 20 --